Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022

 

Upgrades

  • Roth Capital upgraded the previous rating for Denbury Inc DEN from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $91.30 and a 52-week-low of $37.00. At the end of the last trading period, Denbury closed at $66.56.
  • For Pilgrims Pride Corp PPC, Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. In the fourth quarter, Pilgrims Pride showed an EPS of $0.56, compared to $0.25 from the year-ago quarter. The current stock performance of Pilgrims Pride shows a 52-week-high of $29.70 and a 52-week-low of $20.32. Moreover, at the end of the last trading period, the closing price was at $27.83.
  • According to Scotiabank, the prior rating for Marathon Oil Corp MRO was changed from Sector Perform to Sector Outperform. For the fourth quarter, Marathon Oil had an EPS of $0.77, compared to year-ago quarter EPS of $0.12. At the moment, the stock has a 52-week-high of $22.56 and a 52-week-low of $9.11. Marathon Oil closed at $21.89 at the end of the last trading period.
  • According to Needham, the prior rating for Masimo Corp MASI was changed from Hold to Buy. Masimo earned $1.21 in the fourth quarter, compared to $0.98 in the year-ago quarter. The current stock performance of Masimo shows a 52-week-high of $305.21 and a 52-week-low of $133.94. Moreover, at the end of the last trading period, the closing price was at $152.37.
  • According to JP Morgan, the prior rating for JB Hunt Transport Services Inc JBHT was changed from Underweight to Neutral. In the fourth quarter, JB Hunt Transport Servs showed an EPS of $2.28, compared to $1.44 from the year-ago quarter. The stock has a 52-week-high of $208.87 and a 52-week-low of $140.88. At the end of the last trading period, JB Hunt Transport Servs closed at $187.84.
  • Raymond James upgraded the previous rating for Fastly Inc FSLY from Outperform to Strong Buy. For the fourth quarter, Fastly had an EPS of $0.10, compared to year-ago quarter EPS of $0.09. The current stock performance of Fastly shows a 52-week-high of $97.98 and a 52-week-low of $19.13. Moreover, at the end of the last trading period, the closing price was at $19.20.
  • Atlantic Equities upgraded the previous rating for Nutrien Ltd NTR from Underweight to Neutral. In the fourth quarter, Nutrien showed an EPS of $2.47, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $78.76 and a 52-week-low of $52.28. Nutrien closed at $77.17 at the end of the last trading period.
  • For Werner Enterprises Inc WERN, JP Morgan upgraded the previous rating of Underweight to Neutral. Werner Enterprises earned $1.13 in the fourth quarter, compared to $0.89 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.76 and a 52-week-low of $41.44. Werner Enterprises closed at $42.70 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Cognex Corp CGNX was changed from Underweight to Neutral. Cognex earned $0.30 in the fourth quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $92.17 and a 52-week-low of $61.59. At the end of the last trading period, Cognex closed at $61.65.

See all analyst ratings upgrades.

 

Downgrades

  • MoffettNathanson downgraded the previous rating for Altice USA Inc ATUS from Buy to Neutral. Altice USA earned $0.56 in the fourth quarter, compared to $0.60 in the year-ago quarter. The current stock performance of Altice USA shows a 52-week-high of $38.19 and a 52-week-low of $11.12. Moreover, at the end of the last trading period, the closing price was at $11.83.
  • Benchmark downgraded the previous rating for Cooper-Standard Holdings Inc CPS from Buy to Hold. Cooper-Standard Holdings earned $2.94 in the fourth quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $47.85 and a 52-week-low of $14.40. At the end of the last trading period, Cooper-Standard Holdings closed at $15.30.
  • According to Wells Fargo, the prior rating for Brady Corp BRC was changed from Overweight to Equal-Weight. For the second quarter, Brady had an EPS of $0.70, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $61.76 and a 52-week-low of $48.27. At the end of the last trading period, Brady closed at $48.89.
  • According to Pivotal Research, the prior rating for Roku Inc ROKU was changed from Hold to Sell. For the fourth quarter, Roku had an EPS of $0.17, compared to year-ago quarter EPS of $0.49. The current stock performance of Roku shows a 52-week-high of $490.76 and a 52-week-low of $139.47. Moreover, at the end of the last trading period, the closing price was at $144.71.
  • According to Goldman Sachs, the prior rating for Bilibili Inc BILI was changed from Buy to Neutral. For the third quarter, Bilibili had an EPS of $0.65, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $153.57 and a 52-week-low of $28.32. Bilibili closed at $36.54 at the end of the last trading period.
  • Goldman Sachs downgraded the previous rating for Tencent Music Entertainment Group TME from Neutral to Sell. In the third quarter, Tencent Music Enter Gr showed an EPS of $0.09, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.25 and a 52-week-low of $5.36. Tencent Music Enter Gr closed at $5.99 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Heartland Express Inc HTLD was changed from Overweight to Neutral. Heartland Express earned $0.26 in the fourth quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.07 and a 52-week-low of $14.02. Heartland Express closed at $14.49 at the end of the last trading period.
  • RBC Capital downgraded the previous rating for Redfin Corp RDFN from Outperform to Sector Perform. In the fourth quarter, Redfin showed an EPS of $0.27, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $98.44 and a 52-week-low of $25.25. At the end of the last trading period, Redfin closed at $28.64.

See all analyst ratings downgrades.

 

Initiations

  • UBS initiated coverage on Constellation Energy Corp CEG with a Neutral rating. The price target for Constellation Energy is set to $50.00. The current stock performance of Constellation Energy shows a 52-week-high of $56.57 and a 52-week-low of $43.88. Moreover, at the end of the last trading period, the closing price was at $45.29.
  • William Blair initiated coverage on Intellia Therapeutics Inc NTLA with an Outperform rating. Intellia Therapeutics earned $0.97 in the third quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $202.73 and a 52-week-low of $43.86. At the end of the last trading period, Intellia Therapeutics closed at $90.40.
  • With a Buy rating, Stifel initiated coverage on Fathom Digital Manufacturing Corp FATH. The price target seems to have been set at $11.00 for Fathom Digital. The current stock performance of Fathom Digital shows a 52-week-high of $11.50 and a 52-week-low of $5.04. Moreover, at the end of the last trading period, the closing price was at $9.12.
  • With a Buy rating, B of A Securities initiated coverage on AdTheorent Holding Co Inc ADTH. The price target seems to have been set at $10.00 for AdTheorent Holding. The current stock performance of AdTheorent Holding shows a 52-week-high of $11.90 and a 52-week-low of $4.11. Moreover, at the end of the last trading period, the closing price was at $6.42.
  • With an Overweight rating, Cantor Fitzgerald initiated coverage on Oramed Pharmaceuticals Inc ORMP. The price target seems to have been set at $20.00 for Oramed Pharmaceuticals. Oramed Pharmaceuticals earned $0.22 in the first quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $31.54 and a 52-week-low of $6.98. Oramed Pharmaceuticals closed at $10.63 at the end of the last trading period.
  • Cantor Fitzgerald initiated coverage on vTv Therapeutics Inc VTVT with an Overweight rating. The price target for vTv Therapeutics is set to $5.00. In the third quarter, vTv Therapeutics showed an EPS of $0.02, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.79 and a 52-week-low of $0.67. vTv Therapeutics closed at $0.71 at the end of the last trading period.
  • Benchmark initiated coverage on Bridgetown 2 Holdings Ltd BTNB with a Buy rating. The price target for Bridgetown 2 Holdings is set to $17.00. The stock has a 52-week-high of $13.70 and a 52-week-low of $9.79. At the end of the last trading period, Bridgetown 2 Holdings closed at $9.97.
  • RBC Capital initiated coverage on Caribou Biosciences Inc CRBU with an Outperform rating. The price target for Caribou Biosciences is set to $22.00. At the moment, the stock has a 52-week-high of $32.65 and a 52-week-low of $9.34. Caribou Biosciences closed at $10.22 at the end of the last trading period.
  • With an Outperform rating, RBC Capital initiated coverage on Verve Therapeutics Inc VERV. The price target seems to have been set at $42.00 for Verve Therapeutics. For the third quarter, Verve Therapeutics had an EPS of $0.47, compared to year-ago quarter EPS of $3.81. The stock has a 52-week-high of $78.00 and a 52-week-low of $24.75. At the end of the last trading period, Verve Therapeutics closed at $28.02.
  • RBC Capital initiated coverage on Graphite Bio Inc GRPH with a Sector Perform rating. The price target for Graphite Bio is set to $11.00. At the moment, the stock has a 52-week-high of $34.00 and a 52-week-low of $7.59. Graphite Bio closed at $10.99 at the end of the last trading period.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!